Scribe Therapeutics Pioneers Epigenetic Silencing for Cardiovascular Disease, Navigating a Cautious Gene Editing IPO Market
In a striking juxtaposition of industrial heritage and futuristic biotechnology, Scribe Therapeutics, a burgeoning gene...
Knowledge and News for the Global Fight Against Cancer.
In a striking juxtaposition of industrial heritage and futuristic biotechnology, Scribe Therapeutics, a burgeoning gene...
Jazz Pharmaceuticals has announced its acquisition of Actio Biosciences in an upfront deal valued at...
San Diego, CA — August 10, 2026 — Sionna Therapeutics experienced a dramatic collapse in...
The pharmaceutical industry, a crucible of innovation and a beacon of hope for countless patients,...
For decades, lung cancer has been inextricably linked with tobacco use, a perception rooted in...
New York, NY – The Cancer Research Institute (CRI), a global leader in advancing immunotherapy...
In October 2025, the Cancer Research Institute (CRI) made a pivotal announcement, unveiling the IGNITE...
The global scientific community is in mourning following the passing of Susumu Tonegawa, PhD, a...
LifeMine Therapeutics, a pioneering biotechnology firm spearheading innovation in natural product drug discovery under the...
The Cancer Research Institute (CRI), a global leader in funding cutting-edge immunotherapy research, has proudly...